Pages that link to "Q38412832"
Jump to navigation
Jump to search
The following pages link to NKT cell-dependent glycolipid-peptide vaccines with potent anti-tumour activity (Q38412832):
Displaying 10 items.
- From Immunologically Archaic to Neoteric Glycovaccines (Q30238724) (← links)
- Engaging Natural Killer T Cells as 'Universal Helpers' for Vaccination (Q39049093) (← links)
- Expanding the biomass derived chemical space. (Q41671146) (← links)
- Glycolipid-peptide conjugate vaccines enhance CD8+ T cell responses against human viral proteins (Q47144502) (← links)
- Peptide Lipidation - A Synthetic Strategy to Afford Peptide Based Therapeutics (Q47590580) (← links)
- Interleukin-13 peptide vaccine induces protective humoral immunity in murine asthma models (Q50234200) (← links)
- The Conventional Nature of Non-MHC-Restricted T Cells. (Q55399719) (← links)
- α-GalCer and iNKT Cell-Based Cancer Immunotherapy: Realizing the Therapeutic Potentials (Q93062542) (← links)
- Carbohydrate Conjugates in Vaccine Developments (Q94465687) (← links)
- A Designed α-GalCer Analog Promotes Considerable Th1 Cytokine Response by Activating the CD1d-iNKT Axis and CD11b-Positive Monocytes/Macrophages (Q97885518) (← links)